Metraipolis › archive › dc_3c30526df433
Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42738252
- DOI
- 10.3390/cancers18172730
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T05:10:21.075Z
- SHA-256 of the archived text
189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60- Stable URL of this page
https://metraipolis.com/documento/dc_3c30526df433
How to cite
Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252 — Europe PMC (en), https://europepmc.org/article/MED/42738252 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3c30526df433 (Metraipolis archive dc_3c30526df433, sha256 189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60)
BibTeX
@misc{dc3c30526df433,
title = {Association Between Body Mass Index and Treatment Toxicity in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib or Pazopanib — Europe PMC PMID:42738252},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42738252},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3c30526df433; sha256 189949c9cdcb264c05fa2ecee7858b7ff4312e5977583fa795197cf14c934c60},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42738252. Agents can read the archived copy with the MCP tool read_document.